Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/ENGN/Return on equity

enGene Therapeutics Inc. (ENGN) Return on equity

enGene Therapeutics Inc. (ENGN) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to ENGN

Source: SEC XBRL filings · For reference only · Not investment advice

More ENGN financial trends

ENGN RevenueENGN Net incomeENGN Net marginENGN Gross profitENGN Gross marginENGN Operating incomeENGN Operating marginENGN Operating cash flowENGN Free cash flowENGN Capital expendituresENGN Stock buybacksENGN Dividends paidENGN Total assetsENGN Total liabilitiesENGN Shareholders’ equityENGN overview →